This is further compounded by the heterogeneity of breast cancer, which can be generalized by the presence of three receptors: estrogen receptor (ER)‐positive, progesterone receptor (PR)‐positive, and human epidermal growth factor receptor 2 (HER2)‐positive. This evidence concerns the gene ERBB2 and breast carcinoma.